Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease

Leishmaniasis affects approximately 2 million people each year throughout the world. This high incidence is due in part to the lack of an efficacious vaccine. We present evidence that the recombinant leishmanial antigens LmSTI1 and TSA, which we identified and characterized previously, induce excell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Campos-Neto, Antonio, Porrozzi, Renato, Greeson, Kay, Coler, Rhea N., Webb, John R., Seiky, Yasir A. W., Reed, Steven G., Grimaldi, Gabriel
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2001
Matèries:
Fungal and Parasitic Infections
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC98475/
https://ncbi.nlm.nih.gov/pubmed/11349082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.6.4103-4108.2001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars